|
JPS6333341A
(ja)
|
1986-07-28 |
1988-02-13 |
Seitetsu Kagaku Co Ltd |
配糖体の処理方法
|
|
US4843071A
(en)
|
1986-12-05 |
1989-06-27 |
Serotonin Industries Of Charleston |
Method and composition for treating obesity, drug abuse, and narcolepsy
|
|
JP2851054B2
(ja)
|
1989-03-15 |
1999-01-27 |
サントリー株式会社 |
ベンズオキセピン誘導体
|
|
US5169780A
(en)
|
1989-06-22 |
1992-12-08 |
Celgene Corporation |
Enantiomeric enrichment and stereoselective synthesis of chiral amines
|
|
FR2656310B1
(fr)
|
1989-12-22 |
1992-05-07 |
Roussel Uclaf |
Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
|
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
DE69412596T2
(de)
|
1993-03-10 |
1999-03-04 |
Magainin Pharmaceuticals Inc., Plymouth Meeting, Pa. |
Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel
|
|
IT1265001B1
(it)
|
1993-12-16 |
1996-10-17 |
Zambon Spa |
Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
|
|
AU704178B2
(en)
|
1993-12-30 |
1999-04-15 |
Imperial Cancer Research Technology Ltd |
Vertebrate embryonic pattern-inducing hedgehog-like proteins
|
|
US6281332B1
(en)
|
1994-12-02 |
2001-08-28 |
The Johns Hopkins University School Of Medicine |
Hedgehog-derived polypeptides
|
|
AU7364896A
(en)
|
1995-10-10 |
1997-04-30 |
Marilyn Strube |
Treatment of pruritus with vitamin d and analogs thereof
|
|
US6887820B1
(en)
|
1995-12-06 |
2005-05-03 |
Japan Science And Technology Corporation |
Method for producing optically active compounds
|
|
EP0916637B1
(en)
|
1995-12-06 |
2005-04-20 |
Japan Science and Technology Agency |
Process for preparating optically active compounds
|
|
GB9706321D0
(en)
|
1997-03-26 |
1997-05-14 |
Zeneca Ltd |
Catalytic hydrogenation
|
|
US7709454B2
(en)
|
1997-06-20 |
2010-05-04 |
New York University |
Methods and compositions for inhibiting tumorigenesis
|
|
US7741298B2
(en)
|
1997-06-20 |
2010-06-22 |
New York University |
Method and compositions for inhibiting tumorigenesis
|
|
US6238876B1
(en)
|
1997-06-20 |
2001-05-29 |
New York University |
Methods and materials for the diagnosis and treatment of sporadic basal cell carcinoma
|
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
|
US6231875B1
(en)
|
1998-03-31 |
2001-05-15 |
Johnson & Johnson Consumer Companies, Inc. |
Acidified composition for topical treatment of nail and skin conditions
|
|
US6432970B2
(en)
|
1998-04-09 |
2002-08-13 |
Johns Hopkins University School Of Medicine |
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6867216B1
(en)
|
1998-04-09 |
2005-03-15 |
Johns Hopkins University School Of Medicine |
Inhibitors of hedgehog signal pathways, compositions and uses related thereto
|
|
US7291626B1
(en)
*
|
1998-04-09 |
2007-11-06 |
John Hopkins University School Of Medicine |
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
|
|
JP2002522505A
(ja)
*
|
1998-08-13 |
2002-07-23 |
ユニヴァースティ オブ サザーン カリフォルニア |
虚血組織への血流を増加させる方法
|
|
GB9821067D0
(en)
|
1998-09-29 |
1998-11-18 |
Zeneca Ltd |
Transfer hydrogenation process
|
|
US6291516B1
(en)
|
1999-01-13 |
2001-09-18 |
Curis, Inc. |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
|
FR2796938B1
(fr)
|
1999-07-29 |
2004-04-02 |
Ppg Sipsy |
Nouveaux derives chiraux n-substitues de la norephedrine, leur preparation et leur utilisation pour la synthese de composes fonctionnalises optiquement actifs par transfert d'hydrogene
|
|
US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
WO2001019800A2
(en)
|
1999-09-16 |
2001-03-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6993456B2
(en)
|
1999-09-30 |
2006-01-31 |
Rockwell Automation Technologies, Inc. |
Mechanical-electrical template based method and apparatus
|
|
AU781524B2
(en)
|
1999-10-13 |
2005-05-26 |
Johns Hopkins University School Of Medicine, The |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
|
US6552016B1
(en)
|
1999-10-14 |
2003-04-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
AU780612C
(en)
|
1999-10-14 |
2005-10-20 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6893637B1
(en)
|
1999-10-21 |
2005-05-17 |
Zymogenetics, Inc. |
Method of treating fibrosis
|
|
IL133809A0
(en)
|
1999-12-30 |
2001-04-30 |
Yeda Res & Dev |
Steroidal alkaloids and pharmaceutical compositions comprising them
|
|
KR20010077591A
(ko)
|
2000-02-03 |
2001-08-20 |
복성해 |
아라니콜라 프로테오리티쿠스에서 분리한 신규 금속성단백질 분해효소 및 그의 유전자
|
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
JP4808895B2
(ja)
|
2000-03-30 |
2011-11-02 |
キュリス，インコーポレイテッド |
細胞増殖の小型有機分子レギュレーター
|
|
AU2001264595A1
(en)
|
2000-05-19 |
2001-12-03 |
Guilford Pharmaceuticals Inc. |
Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
|
|
US7708998B2
(en)
|
2000-10-13 |
2010-05-04 |
Curis, Inc. |
Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
|
|
US20040060568A1
(en)
|
2000-10-13 |
2004-04-01 |
Henryk Dudek |
Hedgehog antagonists, methods and uses related thereto
|
|
GB0029356D0
(en)
|
2000-12-01 |
2001-01-17 |
Avecia Ltd |
Transfer hydrogenation
|
|
US6456928B1
(en)
|
2000-12-29 |
2002-09-24 |
Honeywell International Inc. |
Prognostics monitor for systems that are subject to failure
|
|
ES2270746T3
(es)
|
2001-03-16 |
2007-12-01 |
Alza Corporation |
Parche transdermico para administrar fentanilo.
|
|
WO2002080952A2
(en)
|
2001-04-09 |
2002-10-17 |
Lorantis Limited |
Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
|
|
AUPR602401A0
(en)
|
2001-06-29 |
2001-07-26 |
Smart Drug Systems Inc |
Sustained release delivery system
|
|
EP1401438B1
(en)
|
2001-07-02 |
2005-09-28 |
Tas, Sinan |
Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
|
|
EP1411938B1
(en)
*
|
2001-07-02 |
2005-07-06 |
Tas, Sinan |
Use of cyclopamine for the manufacture of a medicament for the treatemnt of psoriasis
|
|
RU2308948C2
(ru)
*
|
2001-07-02 |
2007-10-27 |
ТАШ Шинан |
Применение циклопамина для лечения базально-клеточной эпителиомы (карциномы) и других опухолей
|
|
AU2002327390B2
(en)
|
2001-07-27 |
2008-06-26 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
JP2003192919A
(ja)
|
2001-10-17 |
2003-07-09 |
Asahi Denka Kogyo Kk |
難燃性合成樹脂組成物
|
|
US7112690B2
(en)
|
2001-11-09 |
2006-09-26 |
National Research Council Of Canada |
Volatile noble metal organometallic complexes
|
|
US7105637B2
(en)
|
2002-02-15 |
2006-09-12 |
William Marsh Rice University |
Dehydro-estriol (8-DHE3) and dehydro-pregnanetriol (7-DHPT), methods of their synthesis
|
|
AU2003209475A1
(en)
*
|
2002-03-07 |
2003-09-16 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
|
US7655674B2
(en)
|
2002-04-22 |
2010-02-02 |
The Johns Hopkins University |
Modulators of hedgehog signaling pathways, compositions and uses related thereto
|
|
GB0210234D0
(en)
|
2002-05-03 |
2002-06-12 |
Novartis Ag |
Process for the manufacture of organic compounds
|
|
CA2490626A1
(en)
|
2002-06-20 |
2003-12-31 |
Nippon Suisan Kaisha, Ltd. |
Prodrug, medicinal utilization thereof and process for producing the same
|
|
AU2003265853A1
(en)
|
2002-08-29 |
2004-03-19 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
|
GB0221539D0
(en)
|
2002-09-17 |
2002-10-23 |
Medical Res Council |
Methods of treatment
|
|
GB0230217D0
(en)
|
2002-12-27 |
2003-02-05 |
Biotica Tech Ltd |
Borrelidin-producing polyketide synthase and its uses
|
|
FR2850022B1
(fr)
|
2003-01-22 |
2006-09-08 |
Centre Nat Rech Scient |
Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
|
|
WO2004113513A2
(en)
|
2003-06-25 |
2004-12-29 |
Ottawa Health Research Institute |
Methods and compositions for modulating stem cell growth and differentiation
|
|
US20080118493A1
(en)
|
2003-07-15 |
2008-05-22 |
Beachy Philip A |
Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity
|
|
WO2005033288A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
WO2005032343A2
(en)
|
2003-10-01 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog signaling in prostate regeneration neoplasia and metastasis
|
|
US20070231828A1
(en)
|
2003-10-01 |
2007-10-04 |
Johns Hopkins University |
Methods of predicting behavior of cancers
|
|
EP1673437A4
(en)
|
2003-10-01 |
2007-07-11 |
Invitrogen Corp |
COMPOSITIONS AND METHODS FOR SYNTHESIS, PURIFICATION AND DETECTION OF BIOMOLECULES
|
|
WO2005042700A2
(en)
|
2003-10-20 |
2005-05-12 |
The Johns Hopkins University |
Use of hedgehog pathway inhibitors in small-cell lung cancer
|
|
US20070219250A1
(en)
|
2003-11-28 |
2007-09-20 |
Romi Singh |
Pharmaceutical Compositions of Nateglinide
|
|
US8273743B2
(en)
|
2004-04-30 |
2012-09-25 |
Curis, Inc. |
Quinoxaline inhibitors of the hedgehog signalling
|
|
WO2006026430A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Infinity Pharmaceuticals, Inc. |
Cyclopamine analogues and methods of use thereof
|
|
AU2005282722C1
(en)
|
2004-09-02 |
2011-08-18 |
Curis, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
|
WO2006039569A1
(en)
|
2004-09-30 |
2006-04-13 |
The University Of Chicago |
Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents
|
|
KR20070083836A
(ko)
|
2004-10-28 |
2007-08-24 |
아이알엠 엘엘씨 |
헷지혹 경로 조절제로서의 화합물 및 조성물
|
|
US20090208579A1
(en)
*
|
2004-12-27 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
|
|
US20060252073A1
(en)
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
EP1888105A2
(en)
|
2005-05-12 |
2008-02-20 |
Introgen Therapeutics, Inc. |
P53 vaccines for the treatment of cancers
|
|
JP5435946B2
(ja)
|
2005-08-22 |
2014-03-05 |
ジョンズ ホプキンス ユニバーシティ |
疾患を処置するためのヘッジホッグ経路アンタゴニスト
|
|
JP4712524B2
(ja)
|
2005-10-28 |
2011-06-29 |
富士通コンポーネント株式会社 |
入力デバイス及び電子機器
|
|
EP1942879A1
(en)
|
2005-10-31 |
2008-07-16 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
WO2007056135A1
(en)
|
2005-11-04 |
2007-05-18 |
Merck & Co., Inc. |
Method of treating cancers with saha and pemetrexed
|
|
US20090156611A1
(en)
|
2005-11-11 |
2009-06-18 |
Licentia Ltd. |
Mammalian hedgehog signaling modulators
|
|
CA2629814C
(en)
|
2005-11-14 |
2013-12-31 |
Genentech, Inc. |
Bisamide inhibitors of hedgehog signaling
|
|
US20090263317A1
(en)
|
2005-12-15 |
2009-10-22 |
Wei Chen |
Method of screening the activity of the smoothened receptor to identify theraputic modulation agents or diagnose disease
|
|
ATE533497T1
(de)
|
2005-12-27 |
2011-12-15 |
Genentech Inc |
Verfahren zur verwendung von hedgehog-kinase- antagonisten zur behandlung von hedgehog- vermittelten krebs
|
|
EP1818411A1
(en)
|
2006-02-13 |
2007-08-15 |
Lonza AG |
Process for the preparation of optically active chiral amines
|
|
EP1998785A4
(en)
|
2006-02-21 |
2009-06-17 |
Univ Michigan |
TREATMENT OF CANCER BY AN ANTAGONIST OF THE HEDGEHOG SIGNALING PATH
|
|
WO2007123511A2
(en)
|
2006-03-24 |
2007-11-01 |
Infinity Pharmaceuticals, Inc. |
Dosing regimens for the treatment of cancer
|
|
US20090306149A1
(en)
|
2006-04-14 |
2009-12-10 |
Rishi Kumar Jain |
Use of biarylcarboxamies in the treatment of hedgehog pathway-related disorders
|
|
UA93548C2
(uk)
|
2006-05-05 |
2011-02-25 |
Айерем Елелсі |
Сполуки та композиції як модулятори хеджхогівського сигнального шляху
|
|
DE102006031358A1
(de)
*
|
2006-07-05 |
2008-01-17 |
Schott Ag |
Verfahren zur Gehäusung optischer oder optoelektronischer Bauteile, sowie verfahrensgemäß herstellbares optisches oder optoelektronisches Gehäuseelement
|
|
US20100048944A1
(en)
|
2006-07-19 |
2010-02-25 |
Farhad Parhami |
Interactions of hedgehog and liver x receptor signaling pathways
|
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
|
WO2008037732A1
(en)
|
2006-09-29 |
2008-04-03 |
Vib Vzw |
Plant cell lines established from the medicinal plant veratrum californicum
|
|
MX2009003680A
(es)
|
2006-10-05 |
2009-07-17 |
Univ Johns Hopkins |
Formulaciones orales, parenterales y topicas dispersables en agua para farmacos deficientemente solubles en agua con el uso de nanoparticulas polimericas inteligentes.
|
|
CA2667821A1
(en)
|
2006-10-31 |
2008-06-12 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Smoothened polypeptides and methods of use
|
|
US20080103116A1
(en)
|
2006-11-01 |
2008-05-01 |
Jennings-Spring Barbara L |
Method of treatment and compositions of D-chiro inositol and phosphates thereof
|
|
US20080182859A1
(en)
|
2006-11-02 |
2008-07-31 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US9231784B2
(en)
|
2006-11-20 |
2016-01-05 |
Thomson Licensing |
Method for eliminating redundant connections
|
|
BRPI0622138A2
(pt)
|
2006-11-20 |
2011-12-27 |
Satori Pharmaceuticals Inc |
compostos éteis para tratar distérbios neurodegenerativos
|
|
TWI433674B
(zh)
*
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
US20100099116A1
(en)
|
2007-01-12 |
2010-04-22 |
Infinity Discovery, Inc. |
Methods for Analysis of Hedgehog Pathway Inhibitors
|
|
FI123481B
(fi)
|
2007-02-05 |
2013-05-31 |
Upm Kymmene Corp |
Menetelmä painopaperin valmistamiseksi ja seoskoostumus
|
|
US7648994B2
(en)
*
|
2007-03-07 |
2010-01-19 |
Infinity Discovery, Inc. |
Heterocyclic cyclopamine analogs and methods of use thereof
|
|
BRPI0808444A2
(pt)
|
2007-03-07 |
2017-06-06 |
Infinity Discovery Inc |
análogos de ciclopamina lactam e métodos de uso dos mesmos
|
|
AU2008224941C1
(en)
|
2007-03-14 |
2013-06-27 |
Exelixis Patent Company Llc |
Inhibitors of the hedgehog pathway
|
|
KR101473504B1
(ko)
|
2007-03-15 |
2014-12-16 |
노파르티스 아게 |
유기 화합물 및 그의 용도
|
|
US9095589B2
(en)
|
2007-04-05 |
2015-08-04 |
Johns Hopkins University |
Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
|
|
US7691887B2
(en)
|
2007-04-18 |
2010-04-06 |
Merck Sharp & Dohme Corp. |
Triazole derivatives which are SMO antagonists
|
|
WO2008131354A2
(en)
|
2007-04-20 |
2008-10-30 |
The Curators Of The University Of Missouri |
Phytoestrogens as regulators of hedgehog signaling and methods of their use in cancer treatment
|
|
EP2175863B1
(en)
|
2007-07-09 |
2018-03-21 |
Eastern Virginia Medical School |
Substituted nucleoside derivatives with antiviral and antimicrobial properties
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
US7867492B2
(en)
*
|
2007-10-12 |
2011-01-11 |
The John Hopkins University |
Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies
|
|
WO2009074300A2
(en)
|
2007-12-13 |
2009-06-18 |
Siena Biotech S.P.A. |
Hedgehog pathway antagonists and therapeutic applications thereof
|
|
US20100222287A1
(en)
|
2007-12-27 |
2010-09-02 |
Mcgovern Karen J |
Therapeutic Cancer Treatments
|
|
CA2710377A1
(en)
|
2007-12-27 |
2009-07-09 |
Infinity Pharmaceuticals, Inc. |
Therapeutic cancer treatments
|
|
US20100297118A1
(en)
|
2007-12-27 |
2010-11-25 |
Macdougall John |
Therapeutic Cancer Treatments
|
|
CA2710858A1
(en)
|
2007-12-27 |
2009-07-09 |
Infinity Pharmaceuticals, Inc. |
Methods for stereoselective reduction
|
|
WO2009099625A2
(en)
|
2008-02-08 |
2009-08-13 |
The Board Of Regents Of The University Of Texas System |
Cyclopamine tartrate salt and uses thereof
|
|
US20090246841A1
(en)
|
2008-03-26 |
2009-10-01 |
Jamieson Andrew C |
Methods and compositions for production of acetaldehyde
|
|
US20110217294A1
(en)
|
2008-04-11 |
2011-09-08 |
Daniel Fults |
Combination of hgf inhibitor and hedgehog inhibitor to treat cancer
|
|
CL2009001479A1
(es)
|
2008-07-02 |
2010-01-04 |
Infinity Pharmaceuticals Inc |
Metodo para aislar un alcaloide del veratrum desglicosilado que comprende proporcionar un material de planta veratrum, poner en contacto con una solucion acuosa y extraer el material de la planta veratrum con un solvente para proporcionar un extracto que comprende dicho alcaloide.
|
|
CA2636807A1
(en)
|
2008-07-04 |
2010-01-04 |
Steven Splinter |
Methods for obtaining cyclopamine
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
EA020048B1
(ru)
|
2008-09-17 |
2014-08-29 |
Новартис Аг |
Дифосфатная соль n-[6-(цис-2,6-диметилморфолин-4-ил)пиридин-3-ил]-2-метил-4'-(трифторметокси)[1,1'-дифенил]-3-карбоксамида и фармацевтическая композиция
|
|
EP3492492A1
(en)
|
2008-09-22 |
2019-06-05 |
Aileron Therapeutics, Inc. |
Methods for preparing purified polypeptide compositions
|
|
US20100081637A1
(en)
|
2008-10-01 |
2010-04-01 |
Innovia Skincare Corp. |
Eczema treatment with vitamin D and analogs thereof method, composition and cream
|
|
WO2010085654A1
(en)
|
2009-01-23 |
2010-07-29 |
Cancer Research Technology Limited |
Hedgehog pathway inhibitors
|
|
AR077490A1
(es)
|
2009-07-21 |
2011-08-31 |
Novartis Ag |
Composiciones farmaceuticas topicas para el tratamiento de una condicion hiperproliferativa de la piel
|
|
AU2010279325B2
(en)
|
2009-08-05 |
2016-10-20 |
Infinity Pharmaceuticals, Inc. |
Enzymatic transamination of cyclopamine analogs
|
|
WO2011057222A1
(en)
|
2009-11-06 |
2011-05-12 |
Infinity Pharmaceuticals, Inc. |
Oral formulations of a hedgehog pathway inhibitor
|
|
AU2010321773A1
(en)
|
2009-11-20 |
2012-06-14 |
Infinity Pharmaceuticals, Inc. |
Methods and compositions for treating hedgehog-associated cancers
|
|
WO2011088404A1
(en)
|
2010-01-15 |
2011-07-21 |
Infinity Pharmaceuticals , Inc |
Treatment of fibrotic conditions using hedgehog inhibitors
|
|
GB201010954D0
(en)
|
2010-06-29 |
2010-08-11 |
Edko Pazarlama Tanitim Ticaret |
Compositions
|
|
US20120010230A1
(en)
|
2010-07-08 |
2012-01-12 |
Macdougall John R |
Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
|
|
US20120010229A1
(en)
|
2010-07-08 |
2012-01-12 |
Macdougall John R |
Therapeutic regimens for hedgehog-associated cancers
|
|
WO2012037217A1
(en)
|
2010-09-14 |
2012-03-22 |
Infinity Pharmaceuticals, Inc. |
Transfer hydrogenation of cyclopamine analogs
|
|
CN102085176A
(zh)
|
2010-12-31 |
2011-06-08 |
江苏中丹制药有限公司 |
一种纳米级伊曲康唑外用制剂、其制备方法及其用途
|
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
|
EP2753179A4
(en)
|
2011-09-09 |
2015-03-04 |
Univ Leland Stanford Junior |
TOPICAL ITRACONAZOLE FORMULATIONS AND THEIR USE
|
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
|
RU2015128265A
(ru)
|
2012-12-14 |
2017-01-25 |
Треви Терапьютикс, Инк. |
Способы лечения зуда
|
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
|
RU2695815C9
(ru)
|
2014-03-24 |
2019-10-28 |
Гуандун Чжуншэн Фармасьютикал Ко., Лтд |
Хинолиновые производные в качестве ингибиторов smo
|
|
JP6796638B2
(ja)
|
2015-06-04 |
2020-12-09 |
ペレファーム, インク.Pellepharm, Inc. |
ヘッジホッグ阻害性化合物の送達のための局所的製剤及びその使用
|
|
WO2017139497A1
(en)
|
2016-02-11 |
2017-08-17 |
PellePharm, Inc. |
Hedgehog inhibitor for use in relief of and treatment of pruritus or itching
|